In conclusion, we have provided additional independent data supporting the role of MIF as a modifier gene of lung disease in CF; the beneficial effect, however, was limited to the homozygous genotype displaying the lowest transcriptional activity. This evidence concerns the gene MIF and cystic fibrosis.